Clinical Trial

Efficacy and Safety of Yishen Daluo Yin Granule for Relapsing-Remitting Multiple Sclerosis

Name: Efficacy and Safety of Yishen Daluo Yin Granule for Relapsing-Remitting Multiple Sclerosis — clinical trial record (NCT07029867)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The aim of this study is to evaluate the efficacy and safety of YSDLY granule in patients with RRMS. This will be a multi-center, randomized, double-blind, placebo-controlled study.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-06-17.

Trial Details

NCT Number	NCT07029867
Lead Sponsor	Ying Gao Collaborators: First Affiliated Hospital of Jinan University, The Second Hospital of Hebei Medical University, Chinese PLA General Hospital
Conditions	Relapse Remitting Multiple Sclerosis
Enrollment	152 participants
Start Date	2026-03-15
Primary Completion	2026-10-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-04